Cannabinoid signaling and liver therapeutics
Author:
Publisher
Elsevier BV
Subject
Hepatology
Reference29 articles.
1. The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings;Mallat;Br J Pharmacol,2011
2. CB2 receptors as new therapeutic targets during liver diseases;Lotersztajn;Br J Pharmacol,2008
3. Endocannabinoids and the control of energy balance;Matias;Trends Endocrinol Metab,2007
4. Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice;Osei-Hyiaman;J Clin Invest,2008
5. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity;Tam;J Clin Invest,2010
Cited by 119 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Peripherally Selective Cannabinoid Receptor 1 Neutral Antagonist Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice;ACS Pharmacology & Translational Science;2024-08-08
2. Patent review of cannabinoid receptor type 2 (CB 2 R) modulators (2016-present);Expert Opinion on Therapeutic Patents;2024-07-02
3. Programmed cell death, from liver Ischemia–Reperfusion injury perspective: An overview;Heliyon;2024-07
4. Peripherally Restricted CB1 Receptor Inverse Agonist JD5037 Treatment Exacerbates Liver Injury in MDR2-Deficient Mice;Cells;2024-06-25
5. Gut Microbiota-Mediated Alterations of Hippocampal CB1R Regulating the Diurnal Variation of Cognitive Impairment Induced by Hepatic Ischemia–Reperfusion Injury in Mice;Neurochemical Research;2024-06-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3